Organigram Global (OGI) Liabilities and Shareholders Equity (2018 - 2026)

Organigram Global (OGI) reported Liabilities and Shareholders Equity of $380.1 million for Q1 2026, little changed quarter-over-quarter from $380.5 million in Q4 2025.

Organigram Global (OGI) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $380.1 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $380.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (changed N/A YoY), and the FY2025 annual result was $380.5 million, changed N/A from the prior year.
  • Liabilities and Shareholders Equity held at $380.1 million in Q1 2026 per OGI's latest filing, from $380.5 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $408.5 million in Q3 2025 and troughed at $380.1 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Organigram Global 731.20 Mn 673.26 Mn 11.96 Mn 380.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 380.14 Mn
Dec 31, 2025 380.54 Mn
Sep 30, 2025 408.52 Mn
Feb 28, 2021 392.76 Mn
Nov 30, 2020 473.37 Mn
Aug 31, 2020 435.13 Mn
May 31, 2020 310.12 Mn
Feb 29, 2020 502.28 Mn
Nov 30, 2019 469.48 Mn
Aug 31, 2019 324.13 Mn
Aug 31, 2018 302.57 Mn